Bluejay Diagnostics, Inc.
BJDX
$1.47
$0.021.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.78% | 18.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.11% | 27.23% | |||
| Operating Income | -5.11% | -27.23% | |||
| Income Before Tax | -4.95% | -30.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.95% | -30.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.95% | -30.20% | |||
| EBIT | -5.11% | -27.23% | |||
| EBITDA | -5.19% | -27.69% | |||
| EPS Basic | 58.08% | 87.90% | |||
| Normalized Basic EPS | 58.08% | -23.83% | |||
| EPS Diluted | 58.08% | 87.90% | |||
| Normalized Diluted EPS | 58.08% | -23.83% | |||
| Average Basic Shares Outstanding | 150.38% | 5.14% | |||
| Average Diluted Shares Outstanding | 150.38% | 5.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||